DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Roe - 1 Wade - 1 Mariam Sunny - 1 Sriparna Roy - 1 Abigail Summerville - 1 Shilpi Majumdar - 1 Arun Koyyur - 1
Top related locs:
United States Israel Bengaluru New York
Top related orgs:
Foundation Consumer Healthcare - 1 Kelso & Co - 1 Juggernaut Capital Partners - 1 Teva Pharmaceutical Industries - 1 Consumer Healthcare - 1 Bloomberg News - 1 Thomson - 1

Search resuls for: "Foundation Consumer Healthcare"


2 mentions found


☆ Owners of morning-after pill Plan B mulling $4 bln sale of company - source
  + stars: | 2023-07-26 | by ( Abigail Summerville | Thomson Reuters | Abigail Is On The M A Team | ) www.reuters.com   time to read: +2 min
July 26 (Reuters) - The private equity owners of popular emergency contraception pill Plan B, Foundation Consumer Healthcare, have hired advisors to explore options including a potential sale of the company, a person familiar with the matter told Reuters. A sale could value the company at more than $4 billion, the source said, adding that the process is at an early stage. Foundation Consumer Healthcare also owns brands such as Breathe Right nasal strips, Dimetapp, which is a medicine for cough and cold for children and allergy drug Alavert. Foundation Consumer Healthcare or its private-equity owners Kelso & Co and Juggernaut Capital Partners did not immediately respond to a Reuters' request for comment. The report on the potential sale was first reported by Bloomberg News.
Persons: Roe, Wade, Mariam Sunny, Sriparna Roy, Abigail Summerville, Shilpi Majumdar, Arun Koyyur Organizations: Foundation Consumer Healthcare, Reuters, Kelso & Co, Juggernaut Capital Partners, Teva Pharmaceutical Industries, Consumer Healthcare, Bloomberg News, Thomson Locations: United States, Israel, Bengaluru, New York
☆ U.S. FDA changes Plan B label to say it does not cause abortion
  + stars: | 2022-12-23 | by ( ) www.reuters.com   time to read: +1 min
The consumer information distributed with the morning after pill known as Plan B One-Step, which has been available over the counter for everyone since 2013, now makes clear its mechanism of action does not alter the implantantion of an egg. It explains that Plan B One-Step works before the release of an egg from the ovary and as a result, usually stops or delays the release of an egg. The FDA also issued an updated question-and-answer section on its website, where the question "Is Plan B One-Step an abortifacient (causing abortion)" is answered with "No." The FDA said that current science suggests Plan B One-Step works by inhibiting or delaying ovulation and midcycle hormonal changes. Foundation Consumer Healthcare, which owns the Plan B brand, had requested approval to modify some of the mechanism of action information on the label, the U.S. Food and Drug Administration (FDA) said.
0 next >>
Total: 2